Skip to main content

Helix Biopharm(HBP-T)
TSX

Today's Change
Real-Time Last Update

Stocks in play: Helix BioPharma Corp

Baystreet - Fri Dec 31, 2021

Is pleased to provide a corporate update on initiatives that were undertaken by the Company in 2021. During the second half of 2021, the Company initiated efforts to validate Helix; an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, and its lead clinical program with external stakeholders to bring in an outside perspective to the company's strategy and future. Helix BioPharma Corp shares T.HBP are trading unchanged at $0.30.

Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe